For Hometown News
Halifax Health is the first and only healthcare facility in the Volusia-Flagler area to adopt Medtronic's Reveal LINQ Insertable Cardiac Monitor System, the smallest implantable cardiac monitoring device available for patients.
The Daytona Beach-based healthcare system began using the new ICM system earlier this month.
In February, Medtronic Inc. received clearance from the Food and Drug Administration to launch the Reveal LINQ ICM System in the United States.
The device is about one-third the size of a AAA battery, making it more than 80 percent smaller than other ICMs. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient's heart for up to three years, with 20 percent more data memory than its larger predecessor, Reveal XT.
The system provides remote monitoring through the Carelink Network, from which physicians can request notifications if their patients have had cardiac events. The Reveal LINQ ICM is indicated for patients who experience symptoms, such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias.
Placed just beneath the skin through a small incision of less than one centimeter in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted.
To learn more about the Halifax Health Center for Cardiology, visit halifaxhealth.org/heart-care.